$0.1699
0.000900.53%
At close: -
$0.1747
0.004802.83%
After Hours: 7:48 PM EDT
Comments
Loading...
IN8bio Analyst Ratings and Price Targets | NASDAQ:INAB | Benzinga
IN8bio Inc has a consensus price target of $6.1 based on the ratings of 7 analysts. The high is $12 issued by Mizuho on April 24, 2023. The low is $1.2 issued by Jones Trading on February 11, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Jones Trading on March 14, 2025, February 12, 2025, and February 11, 2025, respectively. With an average price target of $5.07 between HC Wainwright & Co., HC Wainwright & Co., and Jones Trading, there's an implied 2800.21% upside for IN8bio Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Jones Trading
Laidlaw & Co.
JonesTrading
EF Hutton
1calculated from analyst ratings
Analyst Ratings for IN8bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/14/2025 | Buy Now | 3334.46% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $8 → $6 | Maintains | Buy | Get Alert |
| 02/12/2025 | Buy Now | 4479.28% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 02/11/2025 | Buy Now | 586.89% | Jones Trading | Soumit Roy32% | → $1.2 | Upgrade | Hold → Buy | Get Alert |
| 11/26/2024 | Buy Now | 4479.28% | HC Wainwright & Co. | Swayampakula Ramakanth50% | → $8 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | 4479.28% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $12.5 → $8 | Maintains | Buy | Get Alert |
| 08/12/2024 | Buy Now | — | Jones Trading | Soumit Roy32% | — | Downgrade | Buy → Hold | Get Alert |
| 06/14/2024 | Buy Now | 3620.66% | Jones Trading | Soumit Roy32% | $5 → $6.5 | Maintains | Buy | Get Alert |
| 06/14/2024 | Buy Now | 7055.12% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $12.5 → $12.5 | Reiterates | Buy → Buy | Get Alert |
| 06/04/2024 | Buy Now | 7055.12% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $12.5 → $12.5 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | 7055.12% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $14 → $12.5 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | 7913.74% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $14 → $14 | Reiterates | Buy → Buy | Get Alert |
| 03/18/2024 | Buy Now | 4193.07% | Laidlaw & Co. | Yale Jen25% | → $7.5 | Initiates | → Buy | Get Alert |
| 03/15/2024 | Buy Now | 7913.74% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $14 → $14 | Reiterates | Buy → Buy | Get Alert |
| 03/13/2024 | Buy Now | 2762.05% | JonesTrading | Soumit Roy32% | → $5 | Initiates | → Buy | Get Alert |
| 11/13/2023 | Buy Now | 7913.74% | HC Wainwright & Co. | Swayampakula Ramakanth50% | → $14 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | Buy Now | 7913.74% | HC Wainwright & Co. | Swayampakula Ramakanth50% | → $14 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | Buy Now | 4479.28% | EF Hutton | Tony Butler42% | → $8 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2023 | Buy Now | 7913.74% | HC Wainwright & Co. | Swayampakula Ramakanth50% | → $14 | Reiterates | Buy → Buy | Get Alert |
| 04/26/2023 | Buy Now | 7913.74% | HC Wainwright & Co. | Swayampakula Ramakanth50% | → $14 | Reiterates | → Buy | Get Alert |
| 04/24/2023 | Buy Now | 6768.92% | Mizuho | Mara Goldstein57% | → $12 | Reiterates | → Buy | Get Alert |
| 04/17/2023 | Buy Now | 4479.28% | EF Hutton | Tony Butler42% | → $8 | Maintains | Buy | Get Alert |
| 03/31/2023 | Buy Now | 4479.28% | EF Hutton | Tony Butler42% | → $8 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | Buy Now | 7913.74% | HC Wainwright & Co. | Swayampakula Ramakanth50% | → $14 | Reiterates | → Buy | Get Alert |
| 03/29/2023 | Buy Now | 4479.28% | EF Hutton | Tony Butler42% | → $8 | Initiates | → Buy | Get Alert |
| 11/11/2022 | Buy Now | 1617.23% | B. Riley Securities | Kalpit Patel41% | $9 → $3 | Downgrade | Buy → Neutral | Get Alert |
| 08/30/2022 | Buy Now | 7913.74% | HC Wainwright & Co. | Swayampakula Ramakanth50% | → $14 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for IN8bio (INAB) stock?
The latest price target for IN8bio (NASDAQ:INAB) was reported by HC Wainwright & Co. on March 14, 2025. The analyst firm set a price target for $6.00 expecting INAB to rise to within 12 months (a possible 3334.46% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for IN8bio (INAB)?
The latest analyst rating for IN8bio (NASDAQ:INAB) was provided by HC Wainwright & Co., and IN8bio maintained their buy rating.
When was the last upgrade for IN8bio (INAB)?
The last upgrade for IN8bio Inc happened on February 11, 2025 when Jones Trading raised their price target to $1.2. Jones Trading previously had a hold for IN8bio Inc.
When was the last downgrade for IN8bio (INAB)?
The last downgrade for IN8bio Inc happened on August 12, 2024 when Jones Trading changed their price target from N/A to N/A for IN8bio Inc.
When is the next analyst rating going to be posted or updated for IN8bio (INAB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IN8bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IN8bio was filed on March 14, 2025 so you should expect the next rating to be made available sometime around March 14, 2026.
Is the Analyst Rating IN8bio (INAB) correct?
While ratings are subjective and will change, the latest IN8bio (INAB) rating was a maintained with a price target of $8.00 to $6.00. The current price IN8bio (INAB) is trading at is $0.17, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
